Abbreviated Breast MR: Early Implementation and Outcomes
Breast MR, with its vascular imaging, is significantly more sensitive in detecting breast cancers than mammography, tomosynthesis, ultrasound, or a combination of both. Currently, guidelines for supplemental screening with breast MR are limited to women with a lifetime risk of >20%. However, recently an abbreviated, or “fast” MR protocol (AB-MR) to be used for screening average risk women with dense breasts has been developed demonstrating excellent sensitivity and specificity. With significantly fewer imaging sequences, AB-MR is expected to increase patient throughput and therefore, significantly reduce cost compared to conventional, full breast MR protocols. Early outcomes, lessons learned and case examples from the early clinical implementation of an AB-MR protocol will be presented.
Contact: Tricia Hatcliff | 650-498-7359 | email@example.com
- Emily F. Conant, MD Professor of Radiology and Chief of Breast Imaging